Biohit’s ColonView validation for colorectal cancer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Biohit’s ColonView validation for colorectal cancer screening program in Brazil

Biohit Oyj Press Release December 20, 2013 at 15:15 local time (EET)  

Barretos Cancer Hospital (BCH) in Brazil starts a clinical study validating Biohit’s ColonView compared as one of the two potential alternatives for the colorectal cancer (CRC) screening program decided to start at BCH in 2015. In contrast to the comparison test, ColonView is rapid test specific for detecting human blood in the stools, derived from CRC and its precursors. Validation of the test in a clinical setting is the necessary first step before consideration for inclusion in a population-based screening program.

Barretos Cancer Hospital is one of the leading cancer hospitals in Brazil, with extensive international network of cancer research institutions in USA, Europe and Latin America.

Chief Medical Director of Biohit Oyj, MD, PhD, Professor Kari Syrjänen: “This is an important and necessary first step in the way towards possible incorporation of ColonView test in a population-based CRC screening program in this country where colorectal cancer is an increasing public health problem.”

Attachment: Suomalainen FIT-testi: Entistä tehokkaampaa suolistosyövän seulontaa (PDF) (in Finnish) Available online: http://www.swiflet.com/bpfionko/oncology/6/1/  

Additional information:

Chief Medical Director of Biohit Oyj, MD, PhD, Professor Kari Syrjänen tel. +358 9 773 861 kari.syrjanen@biohit.fi

CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission is "Innovating for Health". The purpose of the company is to take social responsibility and produce innovation, new technologies and analysis systems for use in medicine, research institutions and industry, helping to promote research and diagnostics and to improve the quality of life of people by preventing disease, human suffering and financial loss. We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in Italy and the United Kingdom. Since 1999, Biohit's series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector. www.biohithealthcare.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 5

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 3

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 9

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
WOLFX Super App Surges with 300% Growth Post-Launch

Updated Category News Views 4

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 2

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
Wuhan Colposcopy Course Advances Non-Invasive Treatments

Updated Category News Views 1

Wuhan's Leap in Colposcopy Training Innovation Talk about shaking things up in the medical world—this 2026 CSCCP-ASCCP Colposcopy Training Course in Wuhan isn't just another run-of-the-mill gathering. It's a heavyweight clash of brainpower between the Chinese and American medical pros in the relentless battle against cervical lesions. But here's where it gets spicy: for...

Continue Reading
Warhound's $200M Bet on Genetic Superdogs

Updated Category News Views 7

Pioneering the Canine Frontier with Genetic Superdogs Well, they'd gone and done it. Launched from the shadows with a fat $200 million seed fund, Warhound's venturing where few have before: crafting America’s homegrown powerhouse of genetically enhanced military dogs. Picture your future Fido with a cyber boost and a genetic upgrade. This is Warhound’s battlefield,...

Continue Reading
Volvo Faces Rough Q3, Plans Strategic Responses

Updated Category News Views 5

Volvo's Bumpy Ride Through Q3 2026 Volvo Cars isn't painting a pretty picture for the third quarter of 2026. Posting an operating income of SEK -3.7 billion and a negative EBIT margin sitting at -5.6%, they're definitely feeling the heat. Market shifts in China and the U.S. are squeezing them, and it shows. Crunching the Numbers Let's break this down. Revenue nose-dived...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 2

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading
dMY IV Settlement: Investor Rights and Key Dates

Updated Category News Views 4

dMY IV Settlement: What You Need to Know Listen up, folks! If you've got a stake in dMY Technology Group, Inc. IV, there's big news brewing. We're talking class action, settlement talks, and a cool $11 million on the line. Let's crack open what this means for you as a holder of dMY IV Class A common stock during December 2021's whirlwind. Who Can Get a Piece of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Metal Roofing Market Growth Expected to Reach $25.8 Billion

Updated Category News Views 56

The Rising Tide of the Metal Roofing Market The global metal roofing market is on track for significant growth, with projections indicating a compound annual growth rate (CAGR) of 5.3% through to 2031. Industry experts forecast that the total sales revenue for metal roofing solutions will reach a remarkable USD 25.8 billion by the end of this period. This remarkable...

Continue Reading
Piper Sandler Elevates Tesla Price Target Amid Growth Prospects

Updated Category News Views 52

Piper Sandler Raises Price Target for Tesla Piper Sandler has updated its price target for Tesla Inc (NASDAQ: TSLA), increasing it from $300 to $310. This change comes with an Overweight rating, signaling strong confidence in the company’s potential for growth. The adjustment is mainly due to improved expectations for vehicle deliveries in the upcoming financial period....

Continue Reading
Market Update: Mexico Stocks Fall Significantly at Close

Updated Category News Views 62

Market Insights: Mexico Stocks Decline The stock market in Mexico experienced a downturn recently, reflecting a challenging economic landscape. The S&P/BMV IPC index concluded the trading session with a notable decrease of 1.01%, highlighting a dip in various sectors and overall investor sentiment. Sector Performance: Key Drivers Behind the Decline Several sectors played...

Continue Reading
How a $100 Investment in Vertiv Holdings Co Could Grow Today

Updated Category News Views 116

The Growth Journey of Vertiv Holdings Co Investing in the stock market is often likened to planting a seed that grows given the right conditions. If you had invested $100 in Vertiv Holdings Co (NYSE: VRT) five years ago, your investment would have blossomed into a staggering $841.40 today. This impressive increase highlights the importance of not just investing, but...

Continue Reading
PACS Group Investors Urged to Act Amid Class Action Lawsuits

Updated Category News Views 143

Understanding PACS Group Class Action Lawsuits In recent developments, PACS Group, Inc. has encountered significant legal challenges as former Louisiana Attorney General Charles C. Foti, Jr., in association with Kahn Swick & Foti, LLC, has alerted investors regarding ongoing class action lawsuits. Investors who experienced losses exceeding $100,000 during the class period...

Continue Reading